Management of Acute Myocardial Infarction with Hematemesis

Initial Assessment and Stabilization

Continuous ECG monitoring with defibrillator capacity should be maintained throughout management, as recommended by the American College of Cardiology, to quickly identify and respond to cardiac complications 1
Oxygen therapy should be administered if saturation is <90% to ensure adequate oxygenation of the myocardium and other tissues, as suggested by the American Heart Association 1

Routine echocardiography should be performed to assess LV and RV function and detect any mechanical complications, as recommended by the European Society of Cardiology, to guide management and treatment 2
Routine echocardiography is also supported by the American College of Cardiology, highlighting its importance in the diagnostic approach for patients with acute myocardial infarction and hematemesis 1

Consider using a proton pump inhibitor (PPI) in combination with dual antiplatelet therapy (DAPT) once antithrombotic therapy is restarted, as this is recommended by the European Society of Cardiology for patients at high risk of gastrointestinal bleeding 3
The use of a PPI with DAPT is further supported by guidelines from the European Heart Journal, emphasizing the importance of balancing bleeding and thrombotic risks 4

If primary PCI is indicated and the patient is hemodynamically stable, use radial rather than femoral access to minimize bleeding risk, as recommended by the American College of Cardiology 1
Consider reduced doses of anticoagulants during the procedure, as suggested by the European Society of Cardiology, to mitigate the risk of bleeding complications 1
Active GI bleeding is a relative contraindication to fibrinolytic therapy, according to the European Heart Journal, due to the increased risk of severe bleeding 5
Primary PCI is strongly preferred if available, as stated by the American College of Cardiology, due to its superior outcomes compared to fibrinolytic therapy 1

Once hemostasis is achieved, restart essential post-MI medications in a stepwise approach, beginning with low-dose aspirin (75-100 mg), as recommended by the European Society of Cardiology, due to its mortality benefit 3
Consider using clopidogrel rather than more potent P2Y12 inhibitors (prasugrel or ticagrelor) due to lower bleeding risk, as suggested by the European Heart Journal 3
Beta-blockers should be initiated orally once the patient is hemodynamically stable, particularly in patients with heart failure or LVEF <40%, as recommended by the European Society of Cardiology 6
ACE inhibitors should be started within 24 hours in patients with heart failure, LV dysfunction, diabetes, or anterior infarct once hemodynamically stable, as suggested by the European Heart Journal 7
High-intensity statin therapy should be initiated as early as possible, as recommended by the European Society of Cardiology, to reduce the risk of further cardiovascular events 7

After hospital discharge, maintain a PPI in combination with DAPT, as this is strongly recommended by the European Society of Cardiology for patients with a history of GI bleeding 3
Consider shortening DAPT duration to 6 months in patients at high risk of severe bleeding complications, as suggested by the European Heart Journal, to balance the risks and benefits of antithrombotic therapy 3
Cardiac rehabilitation should be recommended to all patients after stabilization, as stated by the European Society of Cardiology, to improve outcomes and reduce the risk of future cardiovascular events 2